Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Bilateral implantation of the Tecnis one-piece bifocal intraocular lens

Search Title by author or title

Session Details

Session Title: Presented Poster Session: Multifocal IOLs

Session Date/Time: Monday 12/09/2016 | 09:30-11:00

Paper Time: 09:50

Venue: Poster Village: Pod 1

First Author: : J.Chang HONG KONG

Co Author(s): :                  

Abstract Details

Purpose:

To report visual outcomes, quality of vision, and quality of life after bilateral implantation with a single-piece bifocal diffractive multifocal intraocular lens (MIOL).

Setting:

Hong Kong Sanatorium and Hospital

Methods:

All patients underwent bilateral cataract surgery with implantation of the ZMB00 MIOL (Abbott Medical Optics) at the Hong Kong Sanatorium and Hospital. The monocular and binocular distance, intermediate (67 cm), and near visual acuity (VA) (33 cm); binocular contrast sensitivity; presence of visual symptoms and rate of spectacle independence; and quality of life were reported.

Results:

Seventy-two eyes of 36 patients were included. No intraoperative complications developed. The mean monocular uncorrected VA at distance, intermediate (67 cm), and near (30 cm) were 0.01±0.12 (standard deviation), 0.27±0.17, and 0.10±0.08, respectively. The corresponding mean values for binocular uncorrected VA were -0.05±0.09, 0.14±0.13, and 0.06±0.07,respectively. No eyes lost any corrected distance VA. The binocular contrast sensitivity remained at normal level under photopic and mesopic conditions. Twenty-one (58%) and 21 patients (58%) reported seeing halo around lights and night glare, respectively. Thirty patients (83%) reported complete spectacle independence.

Conclusions:

Implantation of the bifocal MIOL after cataract surgery was safe and resulted in a high rate of spectacle independence.

Financial Disclosure:

The study was partly sponsored by AMO and I receive travel expenses from AMO.

Back to previous